Healthcare is where technology meets humanity at its most vulnerable. Behind every medical device, diagnostic tool, every workflow improvement, every minute saved in a clinic, is a patient who gets home sooner, a family that worries less, a clinician who can provide better care. The opportunity to shape this future is open to anyone with a technology that can make care safer, faster, or more accessible.

Moringa Ventures and Changi General Hospital (CGH) are inviting innovators to be part of that work. Applications are now open for a joint Clinical Innovation Programme designed to help promising teams validate, refine, and deploy their solutions inside a live hospital setting - with commercial and investment support.

We welcome applications from:

• Research-backed teams preparing for incorporation

• Early-stage startups seeking their first clinical validation

• Established companies exploring Singapore as a springboard into Southeast Asia

• International innovators looking for a trusted clinical partner in the region

The Programme is open to innovations across the healthcare and biomedical spectrum — including medical devices, diagnostics, therapeutics, biotech, AI-driven clinical tools, digital health solutions, and robotics. Participating teams will work closely with clinicians and healthcare professionals to better understand patient pathways, operational constraints, and safety requirements, while receiving guidance on validation design and execution.

CGH will provide clinical expertise, infrastructure, and access to real-world environments for validation. This includes supporting problem definition, advising on workflow integration, and enabling the design and implementation of validation studies. Moringa Ventures will support participating startups through its venture platform, working alongside founders to shape commercially viable solutions and prepare for deployment within healthcare systems.

Selected teams may receive investment support of up to S$250,000, alongside dedicated mentorship from domain experts, advisors, and venture partners.

By combining CGH’s clinical expertise with Moringa Ventures’ venture-building approach, the Programme aims to support the development of clinically relevant and scalable technologies, contributing to stronger care delivery systems in Singapore and the region.

Applications are now open and will close on 20 May 2026.

Apply here

Learn more:https://momentumforhealthcare.moringa-ventures.com/

Read more: https://moringa-ventures.com/blog/changi-general-hospital-and-moringa-ventures-partner-to-accelerate-clinical-validation-of-deep-tech-healthcare-solutions